Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Compugen Ltd (CGEN)
NASDAQ:CGEN
Holding CGEN?
Track your performance easily
CGEN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $3.03
Previous Close$1.9
Volume84.45K
Average Volume (3M)262.52K
Market Cap
$170.12M
Enterprise Value$120.79M
Total Cash (Recent Filing)$50.69M
Total Debt (Recent Filing)$1.35M
Price to Earnings (P/E)―
Beta2.29
Next Earnings
Nov 07, 2024EPS Estimate
-$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding86,620,000
10 Day Avg. Volume221,518
30 Day Avg. Volume262,517
Standard Deviation0.35
R-Squared0.15
Alpha-0.00269
Financial Highlights & Ratios
Price to Book (P/B)2.11
Price to Sales (P/S)8.33
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.84
Enterprise Value/Ebitda-5.53
Forecast
1Y Price Target
$4.00Price Target Upside110.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Compugen News
PremiumCompany Announcements
Compugen Shareholders Approve All Proposals
PremiumCompany Announcements
Compugen’s Strategic Milestones Boost Q2 2024 Outlook
PremiumPress Releases
Compugen Reports Second Quarter 2024 Results
PremiumCompany Announcements
Compugen Ltd. Calls for 2024 Shareholder Meeting
PremiumCompany Announcements
Compugen’s COM503 Advances with FDA Nod and Gilead DealOwnership Overview
0.00%
Insiders
3.10% Mutual Funds
9.40% Other Institutional Investors
87.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CGEN FAQ
What was Compugen Ltd’s price range in the past 12 months?
Compugen Ltd lowest stock price was $0.53 and its highest was $3.03 in the past 12 months.
What is Compugen Ltd’s market cap?
Currently, no data Available
When is Compugen Ltd’s upcoming earnings report date?
Compugen Ltd’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Compugen Ltd’s earnings last quarter?
Compugen Ltd released its earnings results on Aug 06, 2024. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.087 by $0.067.
Is Compugen Ltd overvalued?
According to Wall Street analysts Compugen Ltd’s price is currently Undervalued.
Does Compugen Ltd pay dividends?
Compugen Ltd does not currently pay dividends.
What is Compugen Ltd’s EPS estimate?
Compugen Ltd’s EPS estimate is -$0.1.
How many shares outstanding does Compugen Ltd have?
Compugen Ltd has 89,536,430 shares outstanding.
What happened to Compugen Ltd’s price movement after its last earnings report?
Compugen Ltd reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.087. Following the earnings report the stock price went up 4.878%.
Which hedge fund is a major shareholder of Compugen Ltd?
Among the largest hedge funds holding Compugen Ltd’s share is ARK Investment Management LLC. It holds Compugen Ltd’s shares valued at 2M.
---
Compugen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.00 (110.53% Upside)
$4.00 (110.53% Upside)
Blogger Sentiment
Bullish
CGEN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 31.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 7.1%
Last 30 Days ▲ 7.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
80.95%
12-Months-Change
Fundamentals
Return on Equity
-15.84%
Trailing 12-Months
Asset Growth
42.97%
Trailing 12-Months
Company Description
Compugen Ltd
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
---
CGEN Earnings Call
Q2 2024
0:00 / 0:00
---
CGEN Stock 12 Month Forecast
Average Price Target
$4.00
▲(110.53% Upside)
Technical Analysis
Best Analysts Covering CGEN
1 Year
1 Year Success Rate
6/13 ratings generated profit
1 Year Average Return
-7.18%
assigned a buy rating last month
Copying Asthika Goonewardene's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of -7.18% per trade.
---